The latest research showed that aromatase expression may be affected by epigenetic modifications and the binding of differential ERβ to the proximal CYP19A1 promoter, possibly involved in enhanced aromatase transcription during ovarian stimulation in PCOS patients [98]. Here, CYP19A1 is linked to polycystic ovary syndrome.